Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added to the study record history, indicating a minor update to the page. The previous v3.5.2 tag was removed as part of this update.
    Difference
    0.1%
    Check dated 2026-04-30T15:28:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:12.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-18T17:50:26.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:52:32.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Site update adds Revision: v3.4.2 and removes the government funding status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T02:41:18.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and updated operations status information with a link to opm.gov. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:26:48.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.